These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 27126523)

  • 41. Divergent complement system activation in two clinically distinct murine models of multiple sclerosis.
    Linzey M; DiSano K; Welsh N; Pachner A; Gilli F
    Front Immunol; 2022; 13():924734. PubMed ID: 35958570
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A predominant viral epitope recognized by T cells from the periphery and demyelinating lesions of SJL/J mice infected with Theiler's virus is located within VP1(233-244).
    Yauch RL; Kim BS
    J Immunol; 1994 Nov; 153(10):4508-19. PubMed ID: 7525707
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recombinant human IL-6 suppresses demyelination in a viral model of multiple sclerosis.
    Rodriguez M; Pavelko KD; McKinney CW; Leibowitz JL
    J Immunol; 1994 Oct; 153(8):3811-21. PubMed ID: 7930598
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Theiler's virus encephalomyelitis infection as a model for multiple sclerosis: cytokines and pathogenic mechanisms].
    Molina-Holgado E; Areválo-Martín A; Vela JM; Guaza C
    Rev Neurol; 2002 Nov 16-30; 35(10):973-8. PubMed ID: 12436402
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oral administration of live virus protects susceptible mice from developing Theiler's virus-induced demyelinating disease.
    Kang BS; Yahikozawa H; Koh CS; Kim BS
    Virology; 2007 Sep; 366(1):185-96. PubMed ID: 17507073
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Therapeutic effect of anti-αv integrin mAb on Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Tomiki H; Kaneyama T; Kobayashi K; Inaba Y; Ichikawa M; Yagita H; Kim BS; Koh CS
    J Neuroimmunol; 2014 Mar; 268(1-2):25-34. PubMed ID: 24434077
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. VI. Potentiation of demyelination with and characterization of an immunopathologic CD4+ T cell line specific for an immunodominant VP2 epitope.
    Gerety SJ; Rundell MK; Dal Canto MC; Miller SD
    J Immunol; 1994 Jan; 152(2):919-29. PubMed ID: 7506740
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential expression of TGF-beta, IL-2, and other cytokines in the CNS of Theiler's murine encephalomyelitis virus-infected susceptible and resistant strains of mice.
    Chang JR; Zaczynska E; Katsetos CD; Platsoucas CD; Oleszak EL
    Virology; 2000 Dec; 278(2):346-60. PubMed ID: 11118358
    [TBL] [Abstract][Full Text] [Related]  

  • 49. DNA vaccination against Theiler's murine encephalomyelitis virus leads to alterations in demyelinating disease.
    Tolley ND; Tsunoda I; Fujinami RS
    J Virol; 1999 Feb; 73(2):993-1000. PubMed ID: 9882300
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transgenic expression of viral capsid proteins predisposes to axonal injury in a murine model of multiple sclerosis.
    Denic A; Zoecklein L; Kerkvliet J; Papke L; Edukulla R; Warrington A; Bieber A; Pease LR; David CS; Rodriguez M
    Brain Pathol; 2011 Sep; 21(5):501-15. PubMed ID: 21314744
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dynamic changes and molecular analysis of cell death in the spinal cord of SJL mice infected with the BeAn strain of Theiler's murine encephalomyelitis virus.
    Gerhauser I; Li L; Li D; Klein S; Elmarabet SA; Deschl U; Kalkuhl A; Baumgärtner W; Ulrich R; Beineke A
    Apoptosis; 2018 Feb; 23(2):170-186. PubMed ID: 29435686
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapeutic effects of anti-Delta1 mAb on Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Tsugane S; Takizawa S; Kaneyama T; Ichikawa M; Yagita H; Kim BS; Koh CS
    J Neuroimmunol; 2012 Nov; 252(1-2):66-74. PubMed ID: 22944320
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Motor and somatosensory evoked potentials in mice infected with Theiler's murine encephalomyelitis virus.
    Iuliano BA; Schmelzer JD; Thiemann RL; Low PA; Rodriguez M
    J Neurol Sci; 1994 May; 123(1-2):186-94. PubMed ID: 8064313
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Abnormal morphology of myelin and axon pathology in murine models of multiple sclerosis.
    Bando Y; Nomura T; Bochimoto H; Murakami K; Tanaka T; Watanabe T; Yoshida S
    Neurochem Int; 2015 Feb; 81():16-27. PubMed ID: 25595039
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antibody-secreting cells in the central nervous system in an animal model of MS: Phenotype, association with disability, and in vitro production of antibody.
    Pachner AR; Brady J; Narayan K
    J Neuroimmunol; 2007 Oct; 190(1-2):112-20. PubMed ID: 17919740
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. V. Mapping of a dominant immunopathologic VP2 T cell epitope in susceptible SJL/J mice.
    Gerety SJ; Karpus WJ; Cubbon AR; Goswami RG; Rundell MK; Peterson JD; Miller SD
    J Immunol; 1994 Jan; 152(2):908-18. PubMed ID: 7904291
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The pathologic role for COX-2 in apoptotic oligodendrocytes in virus induced demyelinating disease: implications for multiple sclerosis.
    Carlson NG; Hill KE; Tsunoda I; Fujinami RS; Rose JW
    J Neuroimmunol; 2006 May; 174(1-2):21-31. PubMed ID: 16516308
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 5-Fluorouracil and levamisole exacerbate demyelination in susceptible mice infected with Theiler's virus.
    Lucchinetti CF; Kimmel DW; Pavelko K; Rodriguez M
    Exp Neurol; 1997 Sep; 147(1):123-9. PubMed ID: 9294409
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Endogenous presentation of self myelin epitopes by CNS-resident APCs in Theiler's virus-infected mice.
    Katz-Levy Y; Neville KL; Girvin AM; Vanderlugt CL; Pope JG; Tan LJ; Miller SD
    J Clin Invest; 1999 Sep; 104(5):599-610. PubMed ID: 10487774
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Absence of perforin expression confers axonal protection despite demyelination.
    Howe CL; Adelson JD; Rodriguez M
    Neurobiol Dis; 2007 Feb; 25(2):354-9. PubMed ID: 17112732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.